GLP-1s and Liver Cancer Recurrence; IBS Acupuncture; Transmural Healing in Crohn's

— News and commentary from the world of gastroenterology and hepatology

by Ian Ingram, Managing Editor, MedPage Today

July 9, 2026

• 2 min read

Diabetes patients with hepatocellular carcinoma (HCC) experienced longer time to HCC recurrence and longer survival when they initiated a GLP-1 agonist rather than a DPP-4 inhibitor, a target trial emulation study found. (Gut)